@prefix this: <https://w3id.org/np/RArdGgLVhCuuEGw_V9GAs1YB5H5NZUVq6vHJ7d4PuRsXU> .
@prefix sub: <https://w3id.org/np/RArdGgLVhCuuEGw_V9GAs1YB5H5NZUVq6vHJ7d4PuRsXU/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix cito: <http://purl.org/spar/cito/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  sub:ecoli-uti-resistance-levels a obo:ECO_0000000, obo:ECO_0006055;
    dct:description "Resistance proportions across 924,635 Escherichia coli isolates from human urinary tract infections reported to the Dutch ISIS-AR surveillance system by 27 laboratories between 2009 and 2020, ranging from 3.2% for ceftazidime to 38.8% for amoxicillin or ampicillin. 82.0% of isolates came from general practices and 77.2% from female patients.";
    cito:isDocumentedBy <https://doi.org/10.1093/jac/dkae268>;
    rdfs:label "Resistance levels in human urinary Escherichia coli isolates";
    prov:wasGeneratedBy <https://w3id.org/np/RAWcM80NHD-EpGCiDDN2pyF0CFM1AC5YhdlxdvEWzws0U/ecoli-uti-amu-amr> .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0001-5420-949X, orcid:0000-0001-5454-0350,
      orcid:0000-0003-3707-8648;
    prov:wasDerivedFrom <https://doi.org/10.1093/jac/dkae268> .
}

sub:pubinfo {
  obo:ECO_0000000 rdfs:label "evidence" .
  
  obo:ECO_0006055 rdfs:label "high throughput evidence" .
  
  orcid:0000-0001-5420-949X foaf:name "Lapo Mughini-Gras" .
  
  orcid:0000-0001-5454-0350 foaf:name "Anouk P. Meijs" .
  
  orcid:0000-0003-3707-8648 foaf:name "Eelco Franz" .
  
  this: dct:created "2026-09-07T10:58:21Z"^^xsd:dateTime;
    dct:creator <https://w3id.org/np/RAuTlT6ESRHfYrofQSuAQtOHeF6BanRUXJc6eY9kEH5UM/zonmw-bot>;
    dct:license <https://creativecommons.org/publicdomain/zero/1.0/>;
    npx:hasNanopubType obo:ECO_0000000;
    npx:introduces sub:ecoli-uti-resistance-levels;
    rdfs:label "Evidence: Resistance levels in human urinary Escherichia coli isolates";
    nt:wasCreatedFromProvenanceTemplate <https://w3id.org/np/RAefFjYMSnydcZtTqdT8TG8rJeJa76ryG7h10VHQiWKgY>;
    nt:wasCreatedFromPubinfoTemplate <https://w3id.org/np/RACJ58Gvyn91LqCKIO9zu1eijDQIeEff28iyDrJgjSJF8>,
      <https://w3id.org/np/RAoTD7udB2KtUuOuAe74tJi1t3VzK0DyWS7rYVAq1GRvw>, <https://w3id.org/np/RAukAcWHRDlkqxk7H2XNSegc1WnHI569INvNr-xdptDGI>;
    nt:wasCreatedFromTemplate <https://w3id.org/np/RAdK5KmqUZAbLUX2IF29UwZHVyZsBj0i8iSy4bzTZxCtI> .
  
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAq/UT4mEO8sT0Co9F/EBYsf3anJLEeBH0q+JCXbo7FCo+FUXSnic/50bSY5InZoQXt6Qc9QvJgiCe3b/OUr12QqUCQhrofuvRjCusikunl0HFMTLohACpWjtpeq2BY4G/2Vb/EtcgSU7S8SACDt8IEM3UYwFki0HBw1aLbbbVddyIaS7W7dBDye50WuWV6Tt2n4B+fCAwLzLilR44rJom+K93GF2IGH20l83edBVMm7W1xuRwCglHmtu5aM3v3VZfxGoveZEbtMp8LsGFO0IaLOGKi072OocbNZQ08KWNrLLCWwAN79xjb9gKK75AmVcgmQDInqY9P9mBKo85zhxeBwIDAQAB";
    npx:hasSignature "FK3BMjn+tP2FIt3rRwavQP5NwpI3A7i32kSammsS1pX6Y8L9RT8q/F8Hi/IOby7Doc/OvmfUXwhsMcTVR1IZ8ofwrvXY7KSE7ZDCl5zx+UID5sBFvLJoqWoYz968HVWf/BVloI8pgI+zHazh9nnyFLPOI5amtXcsNjJ7+7LhWVjSzq5QD08CwcmaR3kRo77xCizyQiRXpOl1LCor2UodIMJmPhybmZQWPtvwA7dcwp64XfOjjiGSVKWyxUc7xwVJaSsaoaVcdSxGLhkm70CzbDJynetjyXuGX1GLIApwqFXXJ1/o0gTzNxhQvQqr2saJSBd/bv5WS4NIQdJYZdhVwA==";
    npx:hasSignatureTarget this:;
    npx:signedBy <https://w3id.org/np/RAuTlT6ESRHfYrofQSuAQtOHeF6BanRUXJc6eY9kEH5UM/zonmw-bot> .
  
  <https://w3id.org/np/RAuTlT6ESRHfYrofQSuAQtOHeF6BanRUXJc6eY9kEH5UM/zonmw-bot> foaf:name
      "ZonMw Bot" .
}